Utility of a next-generation framework for assessment of genomic damage: A case study using the pharmaceutical drug candidate etoposide.
Environ Mol Mutagen
; 62(9): 512-525, 2021 11.
Article
in En
| MEDLINE
| ID: mdl-34775645
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Etoposide
/
Antineoplastic Agents, Phytogenic
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Environ Mol Mutagen
Journal subject:
BIOLOGIA MOLECULAR
/
SAUDE AMBIENTAL
Year:
2021
Document type:
Article
Affiliation country:
United States
Country of publication:
United States